По вашему запросу найдено документов: 595

Страница 3 из 60

The function of miRNAs in the process of kidney development
Sun, Pengfei, Wang, Jiaqi, Ilyasova, Tatiana, Shumadalova, Alina, Agaverdiev, Murad, Wang, Chunlei (2023)
pathways driving kidney development, this review seeks to elucidate the underlying mechanisms through which
Heterotopic ossification as a side effect of the use of recombinant human bone morphogenetic proteins
Mukhametov, U.F., Lyulin, S.V., Borzunov, D.Y., Gareev, I.F., Beylerli, O.A., Sufianov, A.A. (2022)
to ectopic bone formation in soft tissues. Although the molecular mechanism of HO is not fully understood
БИОХИМИЯ МЫШЕЧНОЙ ТКАНИ В НОРМЕ И ПАТОЛОГИИ
BIOCHEMISTRY OF MUSCLE TISSUE IN NORMAL AND PATHOLOGICAL CONDITIONS
Шакирова, И.И., Янышева, С.А., Shakirova, I.I., Yanysheva, S.A. (2024)
mechanism
Epigenetic Mechanisms of the Influence of Physical Activity on the Development of Atherosclerosis
Mustafin, R.N., Khusnutdinova, E.K. (2024)
This work is an analytical review dedicated to the search for driver mechanisms of epigenetic
COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments
Gilyazova, I., Timasheva, Ya., Karunas, A., Kazantseva, A., Sufianov, A., Mashkin, A., Korytina, G., Wang, Ya., Gareev, I., Khusnutdinova, E. (2023)
forms of the disease. A lot of literature data is devoted to the pathogenetic mechanisms of COVID-19
МЕХАНИЗМ РАЗВИТИЯ ПРОЦЕССОВ СВОБОДНО-РАДИКАЛЬНОГО ОКИСЛЕНИЯ ПРИ ПАТОЛОГИЧЕСКИХ ПРОЦЕССАХ
MECHANISM OF DEVELOPMENT OF FREE RADICAL OXIDATION PROCESSES IN PATHOLOGICAL PROCESSES
ГАБИТОВА, Д.М., GABITOVA, D.M. (2020)
MECHANISM OF DEVELOPMENT OF FREE RADICAL OXIDATION PROCESSES IN PATHOLOGICAL PROCESSES
СИНДРОМ МЮНХМЕЙЕРА: ГЕНЕТИЧЕСКИЕ МЕХАНИЗМЫ, ТЕХНОЛОГИИ ДИАГНОСТИКИ И ЛЕЧЕНИЯ
MUNCHMEYER SYNDROME: GENETIC MECHANISMS, DIAGNOSTIC AND TREATMENT TECHNOLOGIES
Батыршин, А. А., Batyrshin, A.A. (2024)
MUNCHMEYER SYNDROME: GENETIC MECHANISMS, DIAGNOSTIC AND TREATMENT TECHNOLOGIES
NEUROPHARMACOLOGICAL ANALYSIS OF THE ANTIDEPRESSANT ACTION OF 2-[3-METHYL-7-(THIETAN-3-YL)-1-ETHYLXANTH-8-YLTHIO] ACETIC ACID HYDRAZIDE
VALEEVA, L.A., DAVLYATOVA, G.G ., SHIMANOVSKII, N.L. (2020)
article focused on the central mechanisms of action of 2-[3-methyl-7-(thietan-3-yl)-1-ethylxanth-7-ylthio
ИМЕГЛИМИН: ОСОБЕННОСТИ МЕХАНИЗМА ДЕЙСТВИЯ И ПОТЕНЦИАЛЬНЫЕ ПРЕИМУЩЕСТВА
Imeglimin: features of the mechanism of action and potential benefits
Kuznetsov, K.O., Saetova, A.A., Mahmutova, E.I., Bobrik, A.G., Bobrik, D.V., Nagaev, I.R., Khamitova, A.D., Arapieva, A.M., Кузнецов, К.О., Саетова, А.А., Махмутова, Э.И., Бобрик, А.Г., Бобрик, Д.В., Нагаев, И.Р., Хамитова, А.Д., Арапиева, А.М. (2022)
Imeglimin: features of the mechanism of action and potential benefits
MiRNAs and lncRNAs in the regulation of innate immune signaling
Gareev, Ilgiz, de Jesus Encarnacion Ramirez, Manuel, Goncharov, Evgeniy, Ivliev, Denis, Shumadalova, Alina, Ilyasova, Tatiana, Wang, Chunlei (2023)
crucial mechanism in the body. A comprehensive understanding of the signaling mechanisms involved

Страница 3 из 60

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год